Skip to Main Content

Using In Silico Evidence to Accelerate the Regulatory Approval of Cardiovascular Devices

The medical device industry has traditionally relied on bench testing, animal testing, and clinical trials as the primary sources of evidence for establishing the safety and effectiveness of medical devices with regulators.  Increased reliance on computational modeling and simulation (CM&S) during product development has led to the need to establish regulatory frameworks that support the inclusion of this new source of evidence in submissions.  The ASME V&V40 standard on “Verification and Validation in Computational Modeling of Medical Devices” is a central element of the FDA framework.  This standard provides a risk-based framework for establishing the credibility requirements of a computational model by guiding users in establishing & assessing the verification, validation, and uncertainty quantification requirements for a context of use.

This webinar will review the ASME V&V 40 standard along with complementary FDA guidance that outlines a clear and consistent pathway for using CM&S in submissions. Progress in the global acceptance of CM&S evidence will also be reviewed.

Feburary 19, 2025 | 11:00 AM EST

Venue:
Virtual

Register Here

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Overview

  • Use digital engineering in the field of healthcare
  • Vision for digital transformation in healthcare

Who should attend

Anyone in the healthcare industry is directly or remotely involved with cardiovascular operations or workflows. This includes engineers, managers, directors, VPs, and C-level executives in process, production, safety, and regulatory activities.


-